Literature DB >> 20463719

Vaccinate before the next pandemic?

Klaus Stöhr1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20463719     DOI： 10.1038/465161a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  2 in total

1.  Negotiating equitable access to influenza vaccines: global health diplomacy and the controversies surrounding avian influenza H5N1 and pandemic influenza H1N1.

Authors:  David P Fidler
Journal:  PLoS Med       Date:  2010-05-04       Impact factor: 11.069

2.  Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.

Authors:  Iain Stephenson; Karl G Nicholson; Katja Hoschler; Maria C Zambon; Kathy Hancock; Joshua DeVos; Jacqueline M Katz; Michaela Praus; Angelika Banzhoff
Journal:  N Engl J Med       Date:  2008-10-09       Impact factor: 91.245
  2 in total
  16 in total

1.  H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers.

Authors:  Irina Isakova-Sivak; Marina Stukova; Mariana Erofeeva; Anatoly Naykhin; Svetlana Donina; Galina Petukhova; Victoria Kuznetsova; Irina Kiseleva; Tatiana Smolonogina; Irina Dubrovina; Maria Pisareva; Alexandra Nikiforova; Maureen Power; Jorge Flores; Larisa Rudenko
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  A phase II study of an investigational tetravalent influenza vaccine formulation combining MF59®: adjuvanted, pre-pandemic, A/H5N1 vaccine and trivalent seasonal influenza vaccine in healthy adults.

Authors:  Karl-Heinz Herbinger; Frank von Sonnenburg; Hans Dieter Nothdurft; Pamela Perona; Astrid Borkowski; Elena Fragapane; Uwe Nicolay; Ralf Clemens
Journal:  Hum Vaccin Immunother       Date:  2013-09-20       Impact factor: 3.452

3.  Vaccinate for the next H2N2 pandemic now.

Authors:  Gary J Nabel; Chih-Jen Wei; Julie E Ledgerwood
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962

4.  Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets.

Authors:  R Bodewes; J H C M Kreijtz; M M Geelhoed-Mieras; G van Amerongen; R J Verburgh; S E van Trierum; T Kuiken; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

5.  Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses.

Authors:  Jens C Krause; Tshidi Tsibane; Terrence M Tumpey; Chelsey J Huffman; Randy Albrecht; David L Blum; Irene Ramos; Ana Fernandez-Sesma; Kathryn M Edwards; Adolfo García-Sastre; Christopher F Basler; James E Crowe
Journal:  J Virol       Date:  2012-03-28       Impact factor: 5.103

6.  Combined administration of MF59-adjuvanted A/H5N1 prepandemic and seasonal influenza vaccines: long-term antibody persistence and robust booster responses 1 year after a one-dose priming schedule.

Authors:  Pio Lopez; Yolanda Caicedo; Alexandra Sierra; Sandrine Tilman; Ralf Clemens; Angelika Banzhoff
Journal:  Clin Vaccine Immunol       Date:  2013-03-27

7.  Immunogenicity and safety of an inactivated 2012/2013 trivalent influenza vaccine produced in mammalian cell culture (Optaflu®): an open label, uncontrolled study.

Authors:  Christof David Vinnemeier; Johanna Fischer-Herr; Seetha Meyer; Katja Liebig; Wiebke Theeß; Gerd-Dieter Burchard; Jakob P Cramer
Journal:  Hum Vaccin Immunother       Date:  2013-11-15       Impact factor: 3.452

8.  Refining the approach to vaccines against influenza A viruses with pandemic potential.

Authors:  Rita Czako; Kanta Subbarao
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

9.  Effect of influenza A(H5N1) vaccine prepandemic priming on CD4+ T-cell responses.

Authors:  Jennifer L Nayak; Katherine A Richards; Hongmei Yang; John J Treanor; Andrea J Sant
Journal:  J Infect Dis       Date:  2014-11-06       Impact factor: 5.226

10.  Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.

Authors:  Irina Isakova-Sivak; Jørgen de Jonge; Tatiana Smolonogina; Andrey Rekstin; Geert van Amerongen; Harry van Dijken; Justin Mouthaan; Paul Roholl; Victoria Kuznetsova; Elena Doroshenko; Vadim Tsvetnitsky; Larisa Rudenko
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.